The Prognostic Value of Altered eIF3a and Its Association with p27 in Non-Small Cell Lung Cancers

• Jie Shen,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China, Department of Clinical Pharmacy, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, P. R. China

  ⨯
• Ji-Ye Yin,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Xiang-Ping Li,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Zhao-Qian Liu ,

  * E-mail: liuzhaoqian63@126.com

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Ying Wang,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Juan Chen,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Jian Qu,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Xiao-Jing Xu,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Howard Lewis McLeod,

  Affiliation Personalized Medicine Institute, Moffitt Cancer Center, Tampa, Florida, United States of America

  ⨯
• Yi-Jing He,

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯
• Kun Xia,

  Affiliation State Key Laboratory of Medical Genetics, Central South University, Changsha, Hunan, P. R. China

  ⨯
• Yuan-Wei Jia,

  Affiliation Department of Clinical Pharmacy, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, P. R. China

  ⨯
• Hong-Hao Zhou

  Affiliations Institute of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha, Hunan, P. R. China, Institute of Clinical Pharmacology, Hunan Key Laboratory of Pharmacogenetics, Changsha, Hunan 8, P. R. China

  ⨯